Chemocentryx Earnings Estimate

CCXI -  USA Stock  

USD 15.32  0.21  1.39%

Many public companies, such as Chemocentryx, manage the perception of their earnings on regular basis to make sure that analyst estimates are accurate. Future earnings calculations are essential input when attempting to value a firm.
Chemocentryx is projected to generate -1.9267 in earnings per share on 31st of December 2021. Chemocentryx earnings estimates module stress-tests analyst consensus about projected Chemocentryx EPS (Earning Per Share) to derive its highest and lowest estimates based on its historical volatility. Continue to Trending Equities.

Search Earnings Estimates 

 
Refresh
The current Gross Profit is estimated to decrease to about 54.5 M. The current Profit Margin is estimated to decrease to -0.92

Chemocentryx Earnings Estimation Breakdown

Calculation of earning per share of Chemocentryx is based on official Zacks consensus of 3 analysts regarding Chemocentryx future annual earnings. Given the historical accuracy of 79.7%, the future earnings per share of Chemocentryx is estimated to be -1.9267 with the lowest and highest values of -2.24 and -1.33, respectively. Please note that this consensus of annual earnings estimates for Chemocentryx is an estimate of EPS before non-recurring items and including employee stock options expenses
Current EPS
-0.94
4th of August 2021
-2.24
Lowest
Estimated EPS
-1.9267
-1.33
Highest

Chemocentryx Earnings Projection Consensus

Suppose the current estimates of Chemocentryx's value are higher than the current market price of the Chemocentryx stock. In this case, investors may conclude that Chemocentryx is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and Chemocentryx's stock will quickly adjusts to the new information provided by the consensus estimate.
Number of AnalystsHistorical AccuracyCurrent EPSEPS Estimate for 31st of December 2021

3

79.7%

-0.94

-1.9267

Chemocentryx Earnings History

Earnings estimate consensus by Chemocentryx analysts from Wall Street is used by the market to judge Chemocentryx's stock performance. The investors also use these earnings estimates to evaluate and project the stock performance into the future in order to make their investment decisions. However, we recommend analyzing not only Chemocentryx's upcoming profit reports and earnings-per-share forecasts but also compare them to our different valuation methods.

Chemocentryx Quarterly Earnings Before Interest Taxes and Depreciation Amortization EBITDA

(28.31 Million)Share
The current Accumulated Retained Earnings Deficit is estimated to decrease to about (498.1 M). The current Earning Before Interest and Taxes EBIT is estimated to decrease to about (54.1 M) The current Issuance Purchase of Equity Shares is estimated to increase to about 384.1 M, while Weighted Average Shares is projected to decrease to roughly 57.7 M.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Chemocentryx's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Chemocentryx in the context of predictive analytics.
Hype
Prediction
LowEstimated ValueHigh
0.7915.8335.33
Details
Intrinsic
Valuation
LowReal ValueHigh
0.9017.9237.42
Details
Naive
Forecast
LowNext ValueHigh
9.8129.3048.80
Details
6 Analysts
Consensus
LowTarget PriceHigh
17.0028.1751.00
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Chemocentryx. Your research has to be compared to or analyzed against Chemocentryx's peers to derive any actionable benefits. When done correctly, Chemocentryx's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Chemocentryx. Note that many institutional investors and large investment bankers can move markets due to the volume of Chemocentryx assets they manage. They also follow analysts to some degree and often drive overall investor sentiments towards Chemocentryx. With so many stockholders watching consensus numbers, the difference between actual and projected earnings is one of the most critical factors driving Chemocentryx stock price in the short term.

Chemocentryx Earnings per Share Projection vs Actual

Actual Earning per Share of Chemocentryx refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering Chemocentryx predict the company's earnings will be in the future. The higher the earnings per share of Chemocentryx, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.

Chemocentryx Estimated Earnings per Share

For an investor who is primarily interested in generating an income out of investing in entities such as Chemocentryx, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of Chemocentryx should always be considered in relation to other companies to make a more educated investment decision.

Chemocentryx Quarterly Analyst Estimates and Surprise Metrics

Earnings surprises can significantly impact Chemocentryx's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2021-04-29
2021-03-31-0.4195-0.43-0.0105
2021-03-01
2020-12-31-0.3319-0.43-0.098129 
2020-11-09
2020-09-30-0.3557-0.350.0057
2020-08-10
2020-06-30-0.33670.290.6267186 
2020-05-11
2020-03-31-0.2975-0.35-0.052517 
2020-03-10
2019-12-31-0.249-0.26-0.011
2019-11-04
2019-09-30-0.2622-0.220.042216 
2019-08-05
2019-06-30-0.222-0.26-0.03817 
2019-05-06
2019-03-31-0.2563-0.230.026310 
2019-03-11
2018-12-31-0.2678-0.210.057821 
2018-11-08
2018-09-30-0.2453-0.220.025310 
2018-08-09
2018-06-30-0.2329-0.140.092939 
2018-05-09
2018-03-31-0.2442-0.190.054222 
2018-03-09
2017-12-31-0.17620.80.9762554 
2017-11-07
2017-09-30-0.3152-0.130.185258 
2017-08-08
2017-06-30-0.17-0.19-0.0211 
2017-05-10
2017-03-31-0.3-0.120.1860 
2017-03-14
2016-12-31-0.22-0.160.0627 
2016-11-07
2016-09-30-0.08-0.15-0.0787 
2016-08-08
2016-06-300.07-0.22-0.29414 
2016-05-10
2016-03-31-0.27-0.34-0.0725 
2016-03-14
2015-12-31-0.2844-0.260.0244
2015-11-09
2015-09-30-0.28-0.260.02
2015-08-06
2015-06-30-0.28-0.280
2015-05-06
2015-03-31-0.28-0.280
2015-03-12
2014-12-31-0.28-0.280
2014-11-05
2014-09-30-0.28-0.250.0310 
2014-08-05
2014-06-30-0.26-0.28-0.02
2014-05-08
2014-03-31-0.24-0.27-0.0312 
2014-03-13
2013-12-31-0.24-0.220.02
2013-11-07
2013-09-30-0.26-0.220.0415 
2013-08-12
2013-06-30-0.28-0.230.0517 
2013-05-13
2013-03-31-0.26-0.28-0.02
2013-03-13
2012-12-31-0.28-0.280
2012-11-13
2012-09-30-0.22-0.28-0.0627 
2012-08-10
2012-06-30-0.21-0.3-0.0942 
2012-05-10
2012-03-31-0.21-0.28-0.0733 
2012-03-30
2011-12-31None4.3299None

About Chemocentryx Earnings Estimate

The earnings estimate module is a useful tool to check what professional financial analysts are assuming about the future of Chemocentryx earnings. We show available consensus EPS estimates for the upcoming years and quarters. Investors can also examine how these consensus opinions have evolved historically. We show current Chemocentryx estimates, future projections, as well as estimates 1, 2, and three years ago. Investors can search for a specific entity to conduct investment planning and build diversified portfolios. Please note, earnings estimates provided by Macroaxis are the average expectations of expert analysts that we track. If a given stock such as Chemocentryx fails to match professional earnings estimates, it usually performs purely. Wall Street refers to that as a 'negative surprise.' If a company 'beats' future estimates, it's usually called an 'upside surprise.'
Please read more on our stock advisor page.
Last ReportedProjected for 2021
Accumulated Retained Earnings Deficit-485.3 M-498.1 M
Earning Before Interest and Taxes EBIT-52.7 M-54.1 M
Earnings per Basic Share(0.84) (0.91) 
Earnings per Diluted Share(0.84) (0.91) 
Price to Earnings Ratio(73.71) (75.65) 
Earnings Before Interest Taxes and Depreciation Amortization EBITDA-49.9 M-51.3 M
Earnings before Tax-55.4 M-56.8 M
ChemoCentryx, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. ChemoCentryx, Inc. was incorporated in 1996 and is headquartered in Mountain View, California. Chemocentryx operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 133 people.

Chemocentryx Investors Sentiment

The influence of Chemocentryx's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Chemocentryx. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock markets does not have a solid backing from leading economists and market statisticians.

Current Sentiment - CCXI

Chemocentryx Investor Sentiment

Most of Macroaxis users are currently bullish on Chemocentryx. What is your opinion about investing in Chemocentryx? Are you bullish or bearish?
Bullish
Bearish
98% Bullish
2% Bearish
Skip

Pair Trading with Chemocentryx

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Chemocentryx position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Chemocentryx will appreciate offsetting losses from the drop in the long position's value.

Chemocentryx Pair Correlation

Equities Pair Trading Analysis

Correlation analysis and pair trading evaluation for Chemocentryx and Edesa Biotech. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  
Continue to Trending Equities. Note that the Chemocentryx information on this page should be used as a complementary analysis to other Chemocentryx's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.

Complementary Tools for Chemocentryx Stock analysis

When running Chemocentryx price analysis, check to measure Chemocentryx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chemocentryx is operating at the current time. Most of Chemocentryx's value examination focuses on studying past and present price action to predict the probability of Chemocentryx's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Chemocentryx's price. Additionally, you may evaluate how the addition of Chemocentryx to your portfolios can decrease your overall portfolio volatility.
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Go
Money Managers
Screen money managers from public funds and ETFs managed around the world
Go
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Go
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Go
CEO Directory
Screen CEOs from public companies around the world
Go
Fund Screener
Find activelly-traded funds from around the world traded on over 30 global exchanges
Go
Shere Portfolio
Track or share privately all of your investments from the convenience of any device
Go
Transaction History
View history of all your transactions and understand their impact on performance
Go
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Go
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Go
The market value of Chemocentryx is measured differently than its book value, which is the value of Chemocentryx that is recorded on the company's balance sheet. Investors also form their own opinion of Chemocentryx's value that differs from its market value or its book value, called intrinsic value, which is Chemocentryx's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Chemocentryx's market value can be influenced by many factors that don't directly affect Chemocentryx underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Chemocentryx's value and its price as these two are different measures arrived at by different means. Investors typically determine Chemocentryx value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Chemocentryx's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.